Form 4: Intelligent Bio Solutions CEO Harry Simeonidis Receives 40,000 Shares

Harry Simeonidis, CEO of Intelligent Bio Solutions Inc., reports the acquisition of 40,000 shares of common stock on September 25, 2024, as part of a long-term incentive plan.

Summary

• On September 27, 2024, Harry Simeonidis, the CEO of Intelligent Bio Solutions Inc. (INBS), filed a Form 4 with the SEC.
• The report details a transaction on September 25, 2024, where Mr. Simeonidis acquired 40,000 shares of INBS common stock.
• These shares were granted under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan.
• The acquisition price was $0 per share.
• Following the transaction, Mr. Simeonidis beneficially owns 40,408 shares of INBS common stock.
• The reported securities have been adjusted to reflect a 1-for-12 reverse stock split effected on January 26, 2024.
• The reported securities have been adjusted to correct a clerical error that had previously caused the reporting person's holding to be underreported by 59 shares.

Sentiment

Score: 7

Explanation: The document is a standard SEC filing related to executive compensation. It doesn't contain any particularly positive or negative news, but the granting of shares under an incentive plan is generally viewed as a positive sign of aligning management interests with shareholders.

Positives

• The grant of shares to the CEO under the long-term incentive plan aligns his interests with those of the shareholders.
• Correction of a clerical error ensures accurate reporting of beneficial ownership.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The stock grant to the CEO could have a slightly positive impact on shareholder sentiment, as it aligns management's interests with those of the shareholders.

Key Dates

Keywords

Form 4, beneficial ownership, Harry Simeonidis, Intelligent Bio Solutions Inc., INBS, CEO, stock grant, incentive plan